DCF — CITIZENS MEDICAL CENTER
Enterprise Value: $-330.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-330.1M
Enterprise Value
$-103.5M
PV of Cash Flows
$-226.6M
PV of Terminal Value
$-364.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $179.2M | $-21.1M | -12.0% | $-28.6M | $-26.0M |
| Year 2 | $184.6M | $-19.8M | -11.0% | $-27.7M | $-22.9M |
| Year 3 | $190.1M | $-18.5M | -10.0% | $-26.6M | $-20.0M |
| Year 4 | $195.9M | $-18.1M | -9.0% | $-26.4M | $-18.0M |
| Year 5 | $201.7M | $-18.2M | -9.0% | $-26.7M | $-16.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-330.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$174.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12251732688498986
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5